- Home
- ACIU vs BLZE Comparison
ACIU vs BLZE Comparison
Compare ACIU & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- BLZE
- Stock Information
- Founded
- ACIU 2003
- BLZE 2007
- Country
- ACIU Switzerland
- BLZE United States
- Employees
- ACIU N/A
- BLZE N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- BLZE Computer Software: Prepackaged Software
- Sector
- ACIU Health Care
- BLZE Technology
- Exchange
- ACIU Nasdaq
- BLZE Nasdaq
- Market Cap
- ACIU 332.4M
- BLZE 280.2M
- IPO Year
- ACIU 2016
- BLZE 2021
- Fundamental
- Price
- ACIU $2.68
- BLZE $6.37
- Analyst Decision
- ACIU Strong Buy
- BLZE Strong Buy
- Analyst Count
- ACIU 2
- BLZE 4
- Target Price
- ACIU $12.00
- BLZE $11.50
- AVG Volume (30 Days)
- ACIU 132.5K
- BLZE 363.8K
- Earning Date
- ACIU 11-05-2024
- BLZE 02-13-2025
- Dividend Yield
- ACIU N/A
- BLZE N/A
- EPS Growth
- ACIU N/A
- BLZE N/A
- EPS
- ACIU N/A
- BLZE N/A
- Revenue
- ACIU $48,505,404.00
- BLZE $122,579,000.00
- Revenue This Year
- ACIU $85.33
- BLZE $27.53
- Revenue Next Year
- ACIU $80.69
- BLZE $14.73
- P/E Ratio
- ACIU N/A
- BLZE N/A
- Revenue Growth
- ACIU 4097200.00
- BLZE 27.41
- 52 Week Low
- ACIU $2.25
- BLZE $4.91
- 52 Week High
- ACIU $5.14
- BLZE $12.65
- Technical
- Relative Strength Index (RSI)
- ACIU 27.49
- BLZE 42.22
- Support Level
- ACIU $2.62
- BLZE $6.22
- Resistance Level
- ACIU $3.02
- BLZE $6.98
- Average True Range (ATR)
- ACIU 0.15
- BLZE 0.30
- MACD
- ACIU -0.05
- BLZE -0.05
- Stochastic Oscillator
- ACIU 9.52
- BLZE 14.15
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About BLZE Backblaze Inc.
Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and other regions.